References
- Milosavljevic, T.; Kostic-Milosavljevic, M.; Jovanovic, I.; Krstic, M. Complications of Peptic Ulcer Disease. Dig. Dis. 2011, 29, 491–493. DOI: https://doi.org/10.1159/000331517.
- Olbe, L.; Carlsson, E.; Lindberg, P. A Proton-Pump Inhibitor Expedition: The Case Histories of Omeprazole and Esomeprazole. Nat. Rev. Drug Discov. 2003, 2, 132–139. DOI: https://doi.org/10.1038/nrd1010.
- Abelö, A.; Andersson, T. B.; Antonsson, M.; Naudot, A. K.; Skånberg, I.; Weidolf, L. Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes. Drug Metab. Dispos. 2000, 28, 966–972.
- Jana, K.; Bandyopadhyay, T.; Ganguly, B. Stereoselective Metabolism of Omeprazole by Cytochrome P450 2C19 and 3A4: Mechanistic Insights from DFT Study. J. Phys. Chem. B. 2018, 122, 5765–5775. DOI: https://doi.org/10.1021/acs.jpcb.8b01179.
- Denisenko, N. P.; Sychev, D. A.; Sizova, Z. M.; Smirnov, V. V.; Ryzhikova, K. A.; Sozaeva, Z. A.; Grishina, E. A. Urine Metabolic Ratio of Omeprazole in Relation to CYP2C19 Polymorphisms in Russian Peptic Ulcer Patients. Pharmgenomics. Pers. Med. 2017, 10, 253–259. DOI: https://doi.org/10.2147/PGPM.S141935.
- Clausen, F. P.; Mccluskey, K. K.; Preikschat, H. F.; Pedersen, S. B. Process for the preparation of 2-[[(2-pyridinyl)methyl]sulfinyl]-1H-benzimidazoles, WO 9840378, 1998.
- Kato, M.; Toyoshima, Y.; Iwano, N. Production of 2-(2-pyridylmethylsulfinyl)benzimidazole as ulcer inhibitors via S-oxidation using hydrogen peroxide and vanadium catalysts, EP 302720, 1989.
- McManus, J. W.; Anousis, N.; Banks, B. N.; Liu, H.; Zhou, L. Preparation of omeprazole from pyrmetazole, US 6191148, 2001.
- Prasad, K. Durgs Intermediates and an improved process for the preparation of omeprazole, US 6303787, 2001.
- Malhotra, G. Chemical Process Simplification: Improving Productivity and Sustainability, Chapter 5. John Wiley & Sons, Inc.: New Jersey, 2011.
- Bhalerao, D. S.; Kondaiah, G. C. M.; Dwivedi, N.; Mylavarappu, R. K.; Reddy, L. A.; Roy, A.; Nagaraju, G.; Reddy, P. P.; Bhattacharya, A.; Bandichhor, R. Novel Approach to the Synthesis of Omeprazole: An Antipeptic Ulcer Agent. Synth. Commun. 2010, 40, 2983–2987. DOI: https://doi.org/10.1080/00397910903341171.
- Erlandsson, P.; Isaksson, R.; Lorentzon, P.; Lindberg, P. Resolution of the Enantiomers of Omeprazole and Some of Its Analogues by Liquid Chromatography on a Trisphenylcarbamoylcellulose-Based Stationary Phase. The Effect of the Enantiomers of Omeprazole on Gastric Glands. J. Chromatogr. 1990, 532, 305–319. DOI: https://doi.org/10.1016/S0378-4347(00)83781-0.
- Kohl, B.; Senn-Bilfinger, J. Enantiomerically Pure (Pyridylmethylsulfinyl)Benzimidazoles Useful as Drugs, and Their Preparation from Racemates. DE 1992, 4035455, 1-8.
- Lindberg, P. L.; Von Unge, S. Process for the preparation of optically pure crystalline salts of omeprazole, WO 9427988, 1994.
- Cotton, H.; Elebring, T.; Larsson, M.; Li, L.; Sörensen, H.; Unge, S. Asymmetric Synthesis of Esomeprazole. Tetrahedron: Asymmetry 2000, 11, 3819–3825. DOI: https://doi.org/10.1016/S0957-4166(00)00352-9.
- Stepankova, H.; Zezula, J.; Hajicek, J.; Kral, V. Process for preparation of esomeprazole via asymmetric oxidation using hydroperoxide and a chiral metal complex of lactic acid, WO 2010091652, 2010.
- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21154_Nexium.cfm. Accessed 1 May 2020.
- Zhao, W.; Yang, W.; Hao, J. Determination and Thermodynamic Modeling of Solid–Liquid Phase Equilibrium for Esomeprazole Sodium in Monosolvents and in the (Ethanol + Ethyl Acetate) Binary Solvent Mixtures. J. Chem. Eng. Data 2017, 62, 1965–1972. DOI: https://doi.org/10.1021/acs.jced.6b01044.
- Hu, Y.; Wu, G.; Gu, P.; Yang, W.; Wang, C.; Ding, Z.; Cao, Y. Thermodynamic Models for Determination of the Solubility of Omeprazole in Pure and Mixture Organic Solvents from T=(278.15 to 333.15)K. J. Chem. Thermodyn. 2016, 94, 177–185. DOI: https://doi.org/10.1016/j.jct.2015.11.005.
- El-Sayed, A.; Boraie, N.; Ismail, F.; El-Khordagui, L. K.; Khalil, S. Assessment of the Pharmaceutical Quality of Omeprazole Capsule Brands Marketed in Egypt. East. Mediterr. Health J. 2007, 13, 1427–1437. DOI: https://doi.org/10.26719/2007.13.6.1427.
- Kan, S. L.; Lu, J.; Liu, J. P.; Zhao, Y. Preparation and in Vitro/in Vivo Evaluation of Esomeprazole Magnesium-Modified Release Pellets. Drug Deliv. 2016, 23, 866–873. DOI: https://doi.org/10.3109/10717544.2014.919545.
- Barmpalexis, P.; Grypioti, A. Development of a New Esomeprazole Delayed Release Gastro-Resistant Pellet Formulation with Improved Storage Stability. Drug Dev. Ind. Pharm. 2018, 44, 942–952. DOI: https://doi.org/10.1080/03639045.2017.1422513.
- Khan, S.; Boateng, J. Effects of Cyclodextrins (Beta and Gamma) and l-Arginine on Stability and Functional Properties of Mucoadhesive Buccal Films Loaded with Omeprazole for Pediatric Patients. Polymers (Basel) 2018, 10, 157–163.
- The United States Pharmacopeia, Fortieth Edition, the National Formulary, Thirty-five edition. United States Pharmacopeial Convention, Inc., USA, 2017.
- The British Pharmacopeia. Her Majesty's Stationery Office, London, 2016.
- Council of Europe, European Pharmacopoeia, 10th ed.; The Stationery Office: Strasbourg, France, 2019.
- El-Kommos, M. E.; Khashaba, P. Y.; Ali, H. R. H.; El-Wekil, M. M. Different Chromatographic and Electrophoretic Methods for Analysis of Proton Pump Inhibitors (PPIs): A Review. Journal of Liquid Chromatography & Related Technologies 2015, 38, 1639–1659. DOI: https://doi.org/10.1080/10826076.2015.1079722.
- Patel, M. M.; Bhuva, S. D.; Patel, H. D.; Mori, K. N. An Overview of the Recent Developments in Analytical Methodologies for Determination of Proton Pump Inhibitors in Bulk Drugs, Pharmaceuticals and Biological Matrices. Eurasian J. Anal. Chem. 2014, 9, 49–57.
- Patel, M.; Bhuva, S.; Patel, M. Proton Pump Inhibitors: Recent Developments in Analytical Methodologies. Rev. Anal. Chem. 2015, 34, 29-43.
- Espinosa Bosch, M.; Ruiz Sánchez, A. J.; Sánchez Rojas, F.; Bosch Ojeda, C. Analytical Methodologies for the Determination of Omeprazole: An Overview. J. Pharm. Biomed. Anal. 2007, 44, 831–844. DOI: https://doi.org/10.1016/j.jpba.2007.04.022.
- Tye, C. K.; Wang, Z.; Dockens, R. C.; Vakkalagadda, B.; Wang, C.; Zhang, Y.; Su, C. C.; Hageman, M. J. Pre-Absorption Physicochemical Compatibility Assessment of 8-Drug Metabolic Cocktail. Int. J. Pharm. 2016, 514, 364–373. DOI: https://doi.org/10.1016/j.ijpharm.2016.06.028.
- Magalhães, P.; De Andrés, F.; Falcão, A.; LLerena, A.; Alves, G. Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes Be Used in the Rat for Drug Interaction Studies? J. Pharm. Pharm. Sci. 2016, 19, 520–529. DOI: https://doi.org/10.18433/J3D313.
- Garimella, T.; Tao, X.; Sims, K.; Chang, Y. T.; Rana, J.; Myers, E.; Wind-Rotolo, M.; Bhatnagar, R.; Eley, T.; LaCreta, F.; AbuTarif, M. Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects. Drugs R D 2018, 18, 55–65. DOI: https://doi.org/10.1007/s40268-017-0222-8.
- Tachibana, M.; Papadopoulos, K. P.; Strickler, J. H.; Puzanov, I.; Gajee, R.; Wang, Y.; Zahir, H. Evaluation of the Pharmacokinetic Drug Interaction Potential of Tivantinib (ARQ 197) Using Cocktail Probes in Patients with Advanced Solid Tumours. Br. J. Clin. Pharmacol. 2018, 84, 112–121. DOI: https://doi.org/10.1111/bcp.13424.
- Wang, J.; Zhang, Z. Y.; Lu, S.; Powers, D.; Kansra, V.; Wang, X. Effects of Rolapitant Administered Orally on the Pharmacokinetics of Dextromethorphan (CYP2D6), Tolbutamide (CYP2C9), Omeprazole (CYP2C19), Efavirenz (CYP2B6), and Repaglinide (CYP2C8) in Healthy Subjects. Support Care Cancer 2019, 27, 819–827. DOI: https://doi.org/10.1007/s00520-018-4331-x.
- Khatri, A.; Cheng, L.; Camez, A.; Ignatenko, S.; Pang, Y.; Othman, A. A. Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis. Clin. Pharmacokinet. 2019, 58, 805–814. DOI: https://doi.org/10.1007/s40262-018-0730-x.
- Lin, Y.; Wei, Y.; Hu, X.; Wu, M.; Ying, X.; Ding, M. Influences of Oldenlandia Diffusa on the CYP450 Activities in Rats Using a Cocktail Method by UHPLC-MS/MS. Biochem. Res. Int. 2018, 2018, 1467143DOI: https://doi.org/10.1155/2018/1467143.
- Ishii, Y.; Ito, Y.; Matsuki, S.; Sanpei, K.; Ogawa, O.; Takeda, K.; Schuck, E. L.; Uemura, N. Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects. Clin. Transl. Sci. 2018, 11, 477–486. DOI: https://doi.org/10.1111/cts.12557.
- Heo, J. K.; Kim, H. J.; Lee, G. H.; Ohk, B.; Lee, S.; Song, K. S.; Song, I. S.; Liu, K. H.; Yoon, Y. R. Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry. Pharmaceutics 2018, 10, 79–87. DOI: https://doi.org/10.3390/pharmaceutics10030079.
- Cusinato, D. A. C.; Filgueira, G. C. O.; Rocha, A.; Cintra, M.; Lanchote, V. L.; Coelho, E. B. LC-MS/MS Analysis of the Plasma Concentrations of a Cocktail of 5 Cytochrome P450 and P-Glycoprotein Probe Substrates and Their Metabolites Using Subtherapeutic Doses . J. Pharm. Biomed. Anal. 2019, 164, 430–441. DOI: https://doi.org/10.1016/j.jpba.2018.10.029.
- Grangeon, A.; Gravel, S.; Gaudette, F.; Turgeon, J.; Michaud, V. Highly Sensitive LC-MS/MS Methods for the Determination of Seven Human CYP450 Activities Using Small Oral Doses of Probe-Drugs in Human. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2017, 1040, 144–158. DOI: https://doi.org/10.1016/j.jchromb.2016.12.006.
- Wang, Z.; Sun, W.; Lin, Z. F.; Sun, R.; Huang, C. K.; Ye, W. J.; Dong, Y. Y.; Zhang, X. D.; Chen, R. J. A UHPLC-MS/MS Method Coupled with Liquid-Liquid Extraction for the Quantitation of Phenacetin, Omeprazole, Metoprolol, Midazolam and Their Metabolites in Rat Plasma and Its Application to the Study of Four CYP450 Activities. J. Pharm. Biomed. Anal. 2019, 163, 204–210. DOI: https://doi.org/10.1016/j.jpba.2018.10.012.
- Lin, Y.; Wei, Y.; Hu, X.; Wu, M.; Yao, J.; Ying, X.; Fu, X.; Ding, M.; Qiao, L. Evaluation of Lentinan Effects on Cytochrome P450 Activity in Rats by a Cocktail Method. Iran. J. Basic Med. Sci. 2019, 22, 296–301. DOI: https://doi.org/10.22038/ijbms.2019.31611.7611.
- Cheng, C.; Qian, J.; Wang, Z.; Li, W.; Huang, C.; Chen, M.; Dong, Y.; Lian, L.; Sun, W. Influences of Corydalis Decumbens on the Activities of CYP450 Enzymes in Rats with a Cocktail Approach. Biomed. Res. Int. 2019, 2019, 9614781DOI: https://doi.org/10.1155/2019/9614781.
- Jo, J. J.; Jo, J. H.; Kim, S.; Lee, J. M.; Lee, S. Development of a Simultaneous LC-MS/MS Method to Predict in Vivo Drug–drug Interaction in Mice . Arch. Pharm. Res. 2018, 41, 450–458. DOI: https://doi.org/10.1007/s12272-018-1012-8.
- Sreevatsav Adiraju, S. K.; Shekar, K.; Fraser, J. F.; Smith, M. T.; Ghassabian, S. An Improved LC-MS/MS Method for Simultaneous Evaluation of CYP2C9, CYP2C19, CYP2D6 and CYP3A4 Activity. Bioanalysis 2018, 10, 1577–1590. DOI: https://doi.org/10.4155/bio-2018-0102.
- Puris, E.; Pasanen, M.; Gynther, M.; Hakkinen, M. R.; Pihlajamaki, J.; Keranen, T.; Honkakoski, P.; Raunio, H.; Petsalo, A. A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine . Anal. Bioanal. Chem. 2017, 409, 251–268. DOI: https://doi.org/10.1007/s00216-016-9994-x.
- Yang, Y. X.; Metz, D. C. Safety of Proton Pump Inhibitor Exposure. Gastroenterology 2010, 139, 1115–1127. DOI: https://doi.org/10.1053/j.gastro.2010.08.023.
- Hagymasi, K.; Mullner, K.; Herszenyi, L.; Tulassay, Z. Update on the Pharmacogenomics of Proton Pump Inhibitors. Pharmacogenomics 2011, 12, 873–888. DOI: https://doi.org/10.2217/pgs.11.4.
- Park, S.; Hyun, Y. J.; Kim, Y. R.; Lee, J. H.; Ryu, S.; Kim, J. M.; Oh, W. Y.; Na, H. S.; Lee, J. G.; Seo, D. W.; et al. Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers. J. Korean Med. Sci. 2017, 32, 729–736. DOI: https://doi.org/10.3346/jkms.2017.32.5.729.
- Koukoula, M.; Dotsikas, Y.; Molou, E.; Schulpis, K. H.; Thodi, G.; Chatzidaki, M.; Triantafylli, O.; Loukas, Y. L. Study of the Effect of CYP2C19 Polymorphisms on Omeprazole Pharmacokinetics by Utilizing Validated LC-MS/MS and Real Time-PCR Methods. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2017, 1047, 173–179. DOI: https://doi.org/10.1016/j.jchromb.2016.06.046.
- Raidal, S. L.; Andrews, F. M.; Nielsen, S. G.; Trope, G. Pharmacokinetic and Pharmacodynamic Effects of Two Omeprazole Formulations on Stomach pH and Gastric Ulcer Scores. Equine Vet. J. 2017, 49, 802–809. DOI: https://doi.org/10.1111/evj.12691.
- Sudha, T.; Kalan, V.; Reddy, K.; Hemalatha, P. V.; Ravikumar, V. R. An LC- MS/MS Method for the Determination of Omeprazole on Proton Pump Inhibitor in Human Plasma. Indonesian J. Pharm. 2016, 27, 80–91. DOI: https://doi.org/10.14499/indonesianjpharm27iss2pp80.
- Rossi, A.; Castrati, L.; Colombo, P.; Flammini, L.; Barocelli, E.; Bettini, R.; Elviri, L. Development and Validation of a DESI-HRMS/MS Method for the Fast Profiling of Esomeprazole and Its Metabolites in Rat Plasma: A Pharmacokinetic Study. Drug Test. Analysis 2016, 8, 208–213. DOI: https://doi.org/10.1002/dta.1805.
- Al-Ghobashy, M. A.; Kamal, S. M.; El-Sayed, G. M.; Attia, A. K.; Nagy, M.; ElZeiny, A.; Elrakaiby, M. T.; Nooh, M. M.; Abbassi, M.; Aziz, R. K. Determination of Voriconazole and co-Administered Drugs in Plasma of Pediatric Cancer Patients Using UPLC-MS/MS: A Key Step towards Personalized Therapeutics. J Chromatogr B Analyt Technol Biomed Life Sci 2018, 1092, 489–498. DOI: https://doi.org/10.1016/j.jchromb.2018.06.043.
- Liu, D.; Yang, H.; Jiang, J.; Nagy, P.; Shen, K.; Qian, J.; Hu, P. Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers. J. Clin. Pharmacol. 2016, 56, 816–826. DOI: https://doi.org/10.1002/jcph.733.
- Hwang, J. H.; Jeong, J. W.; Song, G. H.; Koo, T. S.; Seo, K. W. Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs. J. Vet. Intern. Med. 2017, 31, 743–750. DOI: https://doi.org/10.1111/jvim.14713.
- Liu, R.; Li, P.; Xiao, J.; Yin, Y.; Sun, Z.; Bi, K.; Li, Q. A Fast, Sensitive, and High Throughput Method for the Determination of Esomeprazole in Dog Plasma by UHPLC-MS/MS: Application to Formulation Development of the Compound Preparation of Esomeprazole. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2017, 1068-1069, 352–357. DOI: https://doi.org/10.1016/j.jchromb.2017.11.002.
- Kim, D.; Park, M. S.; Yoo, B. W.; Hong, T.; Park, S. J.; Kim, C. O. The Safety, Pharmacodynamics, and Pharmacokinetics of Immediate-Release Formulation Containing Esomeprazole 20 mg/Sodium Bicarbonate 800 mg in Healthy Adult Male. Drug Des. Devel. Ther. 2019, 13, 3151–3159. DOI: https://doi.org/10.2147/DDDT.S212491.
- Qadir, N.; Khaliq, T.; Hussain, R. A.; Shah, G. A.; Asharaf, S.; Raza, A.; Noor, N. Renal Clearance and Urinary Excretion of Omeprazole in Healthy Female Volunteers in Pakistan. Pak. J. Pharm. Sci. 2017, 30, 499–505.
- Karami, S.; Dehghanzadeh, G.; Haghighat, M.; Mirzaei, R.; Rahimi, H. R. Pharmacokinetic Comparison of Omeprazole Granule and Suspension Forms in Children: A Randomized, Parallel Pilot Trial. Drug Res. (Stuttg) 2016, 66, 165–168. DOI: https://doi.org/10.1055/s-0035-1564101.
- Horta, R. P.; do Amaral, B.; Peralta-Zamora, P. G.; Silva, B. J. G. Evaluation of a Hollow-Fiber Liquid-Phase Microextraction Technique for the Simultaneous Determination of PPI Drugs in Human Plasma by LC-DAD. J. Chromatogr. Sci. 2018, 56, 564–573. DOI: https://doi.org/10.1093/chromsci/bmy023.
- Zohdi, Z.; Hashemi, M.; Uheida, A.; Moein, M. M.; Abdel-Rehim, M. Graphene Oxide Tablets for Sample Preparation of Drugs in Biological Fluids: Determination of Omeprazole in Human Saliva for Liquid Chromatography Tandem Mass Spectrometry. Molecules 2019, 24, 1191–1199. DOI: https://doi.org/10.3390/molecules24071191.
- Ranjha, N. M.; Rashid, Z.; Razzaq, R.; Raza, H.; Hanif, M.; Mahmood, A. Development and Validation of Fast Reversed-Phase HPLC Method for Analysis of Esomeprazole in Rabbit Plasma. Acta Poloniae Pharmaceutica Drug. Res. 2017, 74, 385–391.
- Sebaiy, M. M.; Hassan, W. S.; Elhennawy, M. E. Developing a High-Performance Liquid Chromatography (HPLC) Method for Simultaneous Determination of Oxytetracycline, Tinidazole and Esomeprazole in Human Plasma. J. Chromatogr. Sci. 2019, 57, 724–729. DOI: https://doi.org/10.1093/chromsci/bmz046.
- Elkady, E. F.; Fouad, M. A.; Jaadan, B. M. LC-MS/MS Bioassay of Four Proton Pump Inhibitors. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2018, 1076, 61–69. DOI: https://doi.org/10.1016/j.jchromb.2018.01.022.
- Talaat, W. Bioanalytical Method for the Estimation of Co-Administered Esomeprazole, Leflunomide and Ibuprofen in Human Plasma and in Pharmaceutical Dosage Forms Using Micellar Liquid Chromatography. Biomed. Chromatogr. 2017, 31, e3865. DOI: https://doi.org/10.1002/bmc.3865.
- Hoover, A.; Sun, D.; Wen, H.; Jiang, W.; Cui, M.; Jiang, X.; Keire, D.; Guo, C. In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules. J. Pharm. Sci. 2017, 106, 1859–1864. DOI: https://doi.org/10.1016/j.xphs.2017.04.008.
- Mabrouk, M. M.; Hammad, S. F.; Mansour, R. R.; El-Khateeb, B. Z. Simultaneous Determination of Diclofenac and Esomeprazole by Reversed Phase Liquid Chromatography, Dual Wavelength and Derivative Spectrophotometry. J. Anal. Chem. 2019, 74, 458–466. DOI: https://doi.org/10.1134/S1061934819050071.
- Smerikarova, M.; Bozhanov, S.; Maslarska, V. Development and Validation of a RP-HPLC Method to Quantify Amoxicillin, Tinidazole, Esomeprazole and Lansoprazole in a Mixture. Indian J. Pharm. Sci. 2019, 81, 1122–1127.
- Ivić, M. A.; Lović, J.; Stevanović, S.; Nikolić, N. D.; Trišović, N.; Lađarević, J.; Vuković, D.; Drmanić, S.; Mladenović, A.; Jadranin, M.; et al. Electrochemical Behavior of Esomeprazole: Its Determination at Au Electrode as Standard and in Injection Powder Combined with the Study of Its Degradation. J. Electroanal. Chem. 2019, 848, 113303. DOI: https://doi.org/10.1016/j.jelechem.2019.113303.
- Altun, M.; Karakaş, D.; Bilsel, G. Residual Thiosulfate Determination in Omeprazole by Liquid Chromatography. J. Chem. Metrol. 2016, 10, 27–31.
- Johansson, E.; Karlsson, A.; Ludvigsson, J. W. Ultra High Performance Liquid Chromatography Method Development for Separation of Omeprazole and Related Substances on Core-Shell Columns Using a Quality by Design Approach. J. Sep. Sci. 2020, 43, 696–707. DOI: https://doi.org/10.1002/jssc.201900726.
- Alfarsi, A.; Dillon, A.; McSweeney, S.; Kruse, J.; Griffin, B.; Devine, K.; Sherry, P.; Henken, S.; Fitzpatrick, S.; Fitzpatrick, D. Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS): a Rapid Test for Enteric Coating Thickness and Integrity of Controlled Release Pellet Formulations. Int. J. Pharm. 2018, 544, 31–38. DOI: https://doi.org/10.1016/j.ijpharm.2018.04.018.
- Kučerová, K.; Reiská, V.; Švec, F.; Krčmová, L. K.; Matysová, L. Fast Determination of Omeprazole in Extemporaneous Suspensions Used in Paediatrics and Stability Studies. Anal. Methods 2019, 11, 517–523. DOI: https://doi.org/10.1039/C8AY02547A.
- Polonini, H. C.; Silva, S. L.; Loures, S.; Almy, R.; Balland, A.; Brandao, M. A. F.; Ferreira, A. O. Compatibility of Proton Pump Inhibitors in a Preservative-Free Suspending Vehicle. Eur. J. Hosp. Pharm. 2018, 25, 150–156. DOI: https://doi.org/10.1136/ejhpharm-2016-001034.
- Åsberg, D.; Chutkowski, M.; Leśko, M.; Samuelsson, J.; Kaczmarski, K.; Fornstedt, T. A Practical Approach for Predicting Retention Time Shifts Due to Pressure and Temperature Gradients in Ultra-High-Pressure Liquid Chromatography. J. Chromatogr. A 2017, 1479, 107–120. DOI: https://doi.org/10.1016/j.chroma.2016.11.050.
- Roberts, J.; McNaughtan, M. L.; MacLachlan, J.; Hunter, C.; Pahl, O. Identification of the Acid-Induced Degradation Products of Omeprazole and 5-Hydroxyomeprazole by High-Resolution Mass Spectrometry. Rapid Commun. Mass Spectrom. 2018, 32, 929–941. DOI: https://doi.org/10.1002/rcm.8120.
- Jadhav, S. B.; Kumar, C. K.; Bandichhor, R.; Bhosale, P. N. Development of RP UPLC-TOF/MS, Stability Indicating Method for Omeprazole and Its Related Substances by Applying Two Level Factorial Design; and Identification and Synthesis of Non-Pharmacopoeial Impurities. J. Pharm. Biomed. Anal. 2016, 118, 370–379. DOI: https://doi.org/10.1016/j.jpba.2015.10.005.
- Bhatt, N. M.; Chavada, V. D.; Sanyal, M.; Shrivastav, P. S. Influence of Organic Modifier and Separation Modes for Lipophilicity Assessment of Drugs Using Thin Layer Chromatography Indices. J. Chromatogr. A 2018, 1571, 223–230. DOI: https://doi.org/10.1016/j.chroma.2018.08.009.
- Papp, L. A.; Gyéresi, A.; Hancu, G.; Mircia, E.; Kelemen, H. Development of a Generic Method for the Determination of Protonpump Inhibitors by Capillary Zoneelectrophoresis. Braz. J. Pharm. Sci. 2019, 55, e17786.
- Maslarska, V.; Bozhanov, S.; Tsvetkova, B.; Peikova, L. High Pressure Liquid Chromatographic Method for Simultaneous Determination of Ketoprofen and Omeprazole. Pharmacia 2018, 65, 3–8.
- Koppala, S.; Reddy, V. R.; Anireddy, J. S. Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Related Substances of Ketoprofen and Omeprazole in Combined Capsule Dosage Form. J. Chromatogr. Sci. 2016, 54, 765–775. DOI: https://doi.org/10.1093/chromsci/bmw008.
- Sharma, S.; Sharma, M. C. Development and Validation of New Analytical Methods for Simultaneous Estimation of Drotaverine Hydrochloride in Combination with Omeprazole in a Pharmaceutical Dosage Form. Arab J. Chem. 2017, 10, S397–S403. DOI: https://doi.org/10.1016/j.arabjc.2012.09.012.
- Patel, V. B.; Patel, A. D.; Shah, D. A. Stability Indicating Liquid Chromatographic Method for Simultaneous Determination of Aspirin and Omeprazole. Curr. Drug Discov. Technol.2018, 15, 351–360. DOI: https://doi.org/10.2174/1570163814666171023144105.
- Kamal, A. H.; Marie, A. A.; Hammad, S. F. Stability Indicating RP-HPLC Method for Simultaneous Determination of Omeprazole and Aspirin in the Presence of Salicylic Acid as Degradation Product. Microchem. J. 2020, 152, 104350. DOI: https://doi.org/10.1016/j.microc.2019.104350.
- Chandarana, C.; Kapupara, P. Quantitative Simultaneous Estimation of Aspirin and Omeprazole by rp-Hplc Method Implementing Aqbd Approach in Pharmaceutical Dosage Form. Int. J. Pharm. Sci. Res. 2019, 10, 3777–3784.
- Kashid, A. M.; Kolhe, O. H. Simultaneous Densitometric Determination of Aspirin and Omeprazole by High-Performance Thin-Layer Chromatography. J. Planar Chromatogr. 2019, 32, 501–504. DOI: https://doi.org/10.1556/1006.2019.32.6.8.
- Hussain, A.; AlAjmi, M. F.; Ali, I. Supramolecular Separation Mechanism of Pentafluorophenyl Column Using Ibuprofen and Omeprazole as Markers: LC-MS and Simulation Study. Biomed. Chromatogr. 2018, 32, e4206DOI: https://doi.org/10.1002/bmc.4206.
- Camacho-Munoz, D.; Kasprzyk-Hordern, B.; Thomas, K. V. Enantioselective Simultaneous Analysis of Selected Pharmaceuticals in Environmental Samples by Ultrahigh Performance Supercritical Fluid Based Chromatography Tandem Mass Spectrometry. Anal. Chim. Acta 2016, 934, 239–251. DOI: https://doi.org/10.1016/j.aca.2016.05.051.
- Zhao, P.; Deng, M.; Huang, P.; Yu, J.; Guo, X.; Zhao, L. Solid-phase Extraction Combined with Dispersive Liquid–liquid Microextraction and Chiral Liquid Chromatography-tandem Mass Spectrometry for the Simultaneous Enantioselective Determination of Representative Proton-pump Inhibitors in Water samples . Anal. Bioanal. Chem. 2016, 408, 6381–6392. DOI: https://doi.org/10.1007/s00216-016-9753-z.
- Wang, L.; Chai, Y.; Zhu, W.; Pan, Y.; Sun, C.; Zeng, S. Doubly Charged Trimeric Cluster Ions: effective in Mutual Chiral Recognition of Tadalafil and Three Proton Pump Inhibitors. Analyst 2017, 142, 745–751. DOI: https://doi.org/10.1039/c6an02666d.
- Kusama, T.; Toda, A.; Shimizu, M.; Uehara, S.; Inoue, T.; Uno, Y.; Utoh, M.; Sasaki, E.; Yamazaki, H. Association with Polymorphic Marmoset Cytochrome P450 2C19 of in Vivo Hepatic Clearances of Chirally Separated R-Omeprazole and S-Warfarin Using Individual Marmoset Physiologically Based Pharmacokinetic Models. Xenobiotica 2018, 48, 1072–1077. DOI: https://doi.org/10.1080/00498254.2017.1393121.
- Ragab, M. A. A.; El-Kimary, E. I. High Performance Liquid Chromatography with Photo Diode Array for Separation and Analysis of Naproxen and Esomeprazole in Presence of Their Chiral Impurities: Enantiomeric Purity Determination in Tablets. J. Chromatogr. A 2017, 1497, 110–117. DOI: https://doi.org/10.1016/j.chroma.2017.03.059.
- Gallinella, B.; Ferretti, R.; Zanitti, L.; Sestili, I.; Mosca, A.; Cirilli, R. Comparison of Reversed-Phase Enantioselective HPLC Methods for Determining the Enantiomeric Purity of (S)-Omeprazole in the Presence of Its Related Substances. J. Pharm. Anal. 2016, 6, 132–136. DOI: https://doi.org/10.1016/j.jpha.2015.11.001.
- Ferretti, R.; Zanitti, L.; Casulli, A.; Cirilli, R. Unusual Retention Behavior of Omeprazole and Its Chiral Impurities B and E on the Amylose Tris (3-Chloro-5-Methylphenylcarbamate) Chiral Stationary Phase in Polar Organic Mode. J. Pharm. Anal. 2018, 8, 234–239. DOI: https://doi.org/10.1016/j.jpha.2018.04.001.
- Zhou, L.; Jiang, S.; Zhang, X.; Fang, L.; Guo, X. Preparation of β-cyclodextrin-gold Nanoparticles Modified Open Tubular Column for Capillary Electrochromatographic Separation of Chiral Drugs . Electrophoresis 2018, 39, 941–947. DOI: https://doi.org/10.1002/elps.201700462.
- Boix, C.; Ibanez, M.; Bagnati, R.; Zuccato, E.; Sancho, J. V.; Hernandez, F.; Castiglioni, S. High Resolution Mass Spectrometry to Investigate Omeprazole and Venlafaxine Metabolites in Wastewater. J. Hazard. Mater. 2016, 302, 332–340. DOI: https://doi.org/10.1016/j.jhazmat.2015.09.059.
- Ibanez, M.; Borova, V.; Boix, C.; Aalizadeh, R.; Bade, R.; Thomaidis, N. S.; Hernandez, F. UHPLC-QTOF MS Screening of Pharmaceuticals and Their Metabolites in Treated Wastewater Samples from Athens. J. Hazard. Mater. 2017, 323, 26–35. DOI: https://doi.org/10.1016/j.jhazmat.2016.03.078.
- Kosma, C. I.; Lambropoulou, D. A.; Albanis, T. A. Photochemical Transformation and Wastewater Fate and Occurrence of Omeprazole: HRMS for Elucidation of Transformation Products and Target and Suspect Screening Analysis in Wastewaters. Sci. Total Environ. 2017, 590-591, 592–601. DOI: https://doi.org/10.1016/j.scitotenv.2017.02.233.
- Sadutto, D.; Alvarez-Ruiz, R.; Pico, Y. Systematic Assessment of Extraction of Pharmaceuticals and Personal Care Products in Water and Sediment Followed by Liquid Chromatography-Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2020, 412, 113–127. DOI: https://doi.org/10.1007/s00216-019-02207-0.
- Tulasi, S. L.; Swamy, A. V. V. S.; Peddi, P.; Ganji, R. R. Development and Validation of Analytical Method for Determination of Esomeprazole in Pharmaceutical Effluents Using Reverse Phase High Performance Liquid Chromatography. Int. J. Pharm. Phytopharmacol. Res. 2019, 9, 71–80.
- Jorge, S. M. A.; Pontinha, A. D. R.; Oliveira-Brett, A. M. Electrochemical Redox Behavior of Omeprazole Using a Glassy Carbon Electrode. Electroanalysis 2010, 22, 625–631. DOI: https://doi.org/10.1002/elan.200900377.
- Mohamed, M. A.; Yehia, A. M.; Banks, C. E.; Allam, N. K. Novel MWCNTs/Graphene Oxide/Pyrogallol Composite with Enhanced Sensitivity for Biosensing Applications. Biosens. Bioelectron. 2017, 89, 1034–1041. DOI: https://doi.org/10.1016/j.bios.2016.10.025.
- Afkhami, A.; Bahiraei, A.; Madrakian, T. Application of Nickel Zinc Ferrite/Graphene Nanocomposite as a Modifier for Fabrication of a Sensitive Electrochemical Sensor for Determination of Omeprazole in Real Samples. J Colloid Interface Sci 2017, 495, 1–8. DOI: https://doi.org/10.1016/j.jcis.2017.01.116.
- Atta, N. F.; Galal, A.; El-Ads, E. H.; Galal, A. E. New Insight in Fabrication of a Sensitive Nano-Magnetite/Glutamine/Carbon Based Electrochemical Sensor for Determination of Aspirin and Omeprazole. J. Electrochem. Soc. 2019, 166, B161–B172. DOI: https://doi.org/10.1149/2.1241902jes.
- Arab, N.; Fotouhi, L.; Dorraji, P. S.; Sargazi, G. Signal Amplification for Simultaneous Determination of Two Proton Pump Inhibitors in Biological Matrix Based on Newly Synthesized Metal Organic Framework and Polymeric Film. J. Electroanal. Chem. 2020, 860, 113923. DOI: https://doi.org/10.1016/j.jelechem.2020.113923.
- El-Wekil, M. M.; Alkahtani, S. A.; Ali, H. R. H.; Mahmoud, A. M. Advanced Sensing Nanomaterials Based Carbon Paste Electrode for Simultaneous Electrochemical Measurement of Esomeprazole and Diclofenac Sodium in Human Serum and Urine Samples. J. Mol. Liq. 2018, 262, 495–503. DOI: https://doi.org/10.1016/j.molliq.2018.04.120.
- Stefano, J. S.; Tormin, T. F.; da Silva, J. P.; Richter, E. M.; Munoz, R. A. A. Amperometric Determination of Omeprazole on Screen-Printed Electrodes Using Batch Injection Analysis. Microchem. J. 2017, 133, 398–403. DOI: https://doi.org/10.1016/j.microc.2017.04.007.
- Stefano, J. S.; Rocha, D. P.; Dornellas, R. M.; Narciso, L. C. D.; Krzyzaniak, S. R.; Mello, P. A.; Nossol, E.; Richter, E. M.; Munoz, R. A. A. Highly Sensitive Amperometric Detection of Drugs and Antioxidants on Non-Functionalized Multi-Walled Carbon Nanotubes: Effect of Metallic Impurities?. Electrochim. Acta 2017, 240, 80–89. DOI: https://doi.org/10.1016/j.electacta.2017.04.050.
- Nassar, M. Y.; El-Shahat, M. F.; Khalil, S. M.; El-Moety, E. A. Optimization and Validation of Spectrophotometric and Potentiometric Methods for Determination of Lansoprazole and Omeprazole in Pure and Capsules. Indian J. Pharm. Sci. 2017, 79, 420–430.
- Lotfy, H. M.; Hegazy, M. A.; Mowaka, S.; Mohamed, E. H. Validated Spectrophotometric Methods for Simultaneous Determination of Omeprazole, Tinidazole and Doxycycline in Their Ternary Mixture. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2016, 153, 321–332. DOI: https://doi.org/10.1016/j.saa.2015.07.106.
- Qayoom, A.; Nadir Ali, S.; Sultana, N.; Arayne, M. Synthesis and Spectrophotometric Study of Omeprazole Charge Transfer Complexes with Bromothymol Blue, Methyl Orange and Picric Acid. Moroccan J. Chem. 2017, 5, 212–226.
- Mahmoud, A. M.; Ahmed, S. A. A Validated High-Throughput Fluorometric Method for Determination of Omeprazole in Quality Control Laboratory via Charge Transfer Sensitized Fluorescence. J. Fluoresc. 2016, 26, 521–529. DOI: https://doi.org/10.1007/s10895-015-1737-4.
- Saima, J.; Shah, M. R.; Asma, R.; Saba, R.; Abdul, J. Bhanger*, M. I. 2,4-Dinitrophenylhydrazine Dithiocarbamate Modified Silver Nanoparticles as Sensor for the Colorimetric Determination of Omeprazole. Curr. Anal. Chem. 2017, 13, 532–539.
- Nassar, M.; El-Moety, E.; El-Shahat, M. F. Synthesis and Characterization of a ZnMn 2 O 4 Nanostructure as a Chemical Nanosensor: A Facile and New Approach for Colorimetric Determination of Omeprazole and Lansoprazole Drugs. RSC Adv. 2017, 7, 43798–43811. DOI: https://doi.org/10.1039/C7RA08010G.
- Khashaba, P. Y.; Ali, H. R. H.; El-Wekil, M. M. A Rapid Fourier Transform Infrared Spectroscopic Method for Analysis of Certain Proton Pump Inhibitors in Binary and Ternary Mixtures. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2018, 190, 10–14. DOI: https://doi.org/10.1016/j.saa.2017.09.003.
- Kiran, B.; Raja, S. Method Development and Validation for the Estimation of Magnesium Content in Esomeprazole Magnesium by Atomic Absorption Spectrophotometer. Orient. J. Chem. 2018, 34, 502–506. DOI: https://doi.org/10.13005/ojc/340155.
- Mattiazzi, P.; Bohrer, D.; Becker, E.; Viana, C.; Nascimento, P. C.; Carvalho, L. M. High-Resolution Continuum Source Graphite Furnace Atomic Absorption Spectrometry for Screening Elemental Impurities in Drugs to Adhere to the New International Guidelines. Talanta 2019, 197, 20–27. DOI: https://doi.org/10.1016/j.talanta.2018.12.068.
- Pinheiro, F. C.; Barros, A. I.; Nobrega, J. A. Elemental Impurities Analysis in Name-Brand and Generic Omeprazole Drug Samples. Heliyon 2020, 6, e03359DOI: https://doi.org/10.1016/j.heliyon.2020.e03359.
- International Conference on Harmonization (ICH). Guideline for Elemental Impurities, https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-32.pdf.
- Skieneh, J.; Khalili Najafabadi, B.; Horne, S.; Rohani, S. Crystallization of Esomeprazole Magnesium Water/Butanol Solvate. Molecules 2016, 21, 544–553. DOI: https://doi.org/10.3390/molecules21040544.
- Šahnić, D.; Mestrović, E.; Jednačak, T.; Habinovec, I.; Vuković, J.; Novak, P. Monitoring and Quantification of Omeprazole Synthesis Reaction by in-Line Raman Spectroscopy and Characterization of the Reaction Components. Org. Process Res. Dev. 2016, 20, 2092–2099. DOI: https://doi.org/10.1021/acs.oprd.6b00323.
- Russo, M. G.; Sancho, M. I.; Silva, L. M.; Baldoni, H. A.; Venancio, T.; Ellena, J.; Narda, G. E. Looking for the Interactions between Omeprazole and Amoxicillin in a Disordered Phase. An Experimental and Theoretical study. Spectrochim. Acta. A Mol. Biomol. Spectrosc. 2016, 156, 70–77. DOI: https://doi.org/10.1016/j.saa.2015.11.021.
- Redondo, J.; Jaime, C.; Marques, A. Selective Deuteration of [(Pyridylmethyl)Sulfinyl]Benzimidazole Antisecretory Drugs. A NMR Study Where DMSO-d6 Acts as Deuteration Agent. J. Pharm. Biomed. Anal. 2016, 131, 454–463. DOI: https://doi.org/10.1016/j.jpba.2016.09.020.
- Assemat, G.; Gouilleux, B.; Bouillaud, D.; Farjon, J.; Gilard, V.; Giraudeau, P.; Malet-Martino, M. Diffusion-Ordered Spectroscopy on a Benchtop Spectrometer for Drug Analysis. J. Pharm. Biomed. Anal. 2018, 160, 268–275. DOI: https://doi.org/10.1016/j.jpba.2018.08.011.
- Rahman, M. S.; Yoshida, N.; Sugiura, S.; Tsuboi, H.; Keila, T.; Kiet, H. B.; Zin, T.; Tanimoto, T.; Kimura, K. Quality of Omeprazole Purchased via the Internet and Personally Imported into Japan: comparison with Products Sampled in Other Asian Countries. Trop. Med. Int. Health 2018, 23, 263–269. DOI: https://doi.org/10.1111/tmi.13028.
- Lee, Y.; Han, J.; Kim, J.; Woo, Y. A.; Chung, H. A Sample Wetting Strategy to Overcome Differences in Physical Morphology between Lab-Prepared Training Samples and Pharmaceutical Process Samples for Reliable Quantitative Raman Spectroscopic Analysis. Analyst 2019, 144, 2403–2410. DOI: https://doi.org/10.1039/c8an02460j.
- Derayea, S. M.; Tsujino, H.; Oyama, Y.; Ishikawa, Y.; Yamashita, T.; Uno, T. Investigation on Drug-Binding in Heme Pocket of CYP2C19 with UV-Visible and Resonance Raman Spectroscopies. Spectrochim Acta A: Mol. Biomol. Spectrosc. 2019, 209, 209–216. DOI: https://doi.org/10.1016/j.saa.2018.10.045.